Envigo Appoints CFO

Patricia Henahan has been appointed chief financial officer, Envigo.
 
Ms. Henahan has extensive financial experience in the life sciences sector, including leadership roles at Eli Lilly, AstraZeneca, MedImmune and Hospira. She brings expertise in financial analysis, strategic planning, R&D and operations, as well as driving continuous improvement.
 
“I am delighted that Pat has decided to join the team at Envigo,” said Brian Cass, chief executive officer. “Her background in pharmaceuticals and experience across the R&D process will bring valuable insight to our strategic planning as we continue to position Envigo as a leading provider of contract services and research models globally.”
 
Prior to joining the company, Ms. Henahan was vice president of finance for Hospira’s $3 billion U.S. pharmaceutical business and was a key member of the executive team delivering double digit profit growth during her time there. Previously she was chief financial officer of the AstraZeneca Group company iPR Pharmaceuticals. Ms Henahan also served for 10 years as a U.S. Army Captain in the Medical Corps.
 
Envigo provides research services, models and products for pharmaceutical, crop protection, and chemical companies.